General
Preferred name
VANCOMYCIN HYDROCHLORIDE
Synonyms
Vancomycin hydrochloride from Streptomyces orientalis ()
Vancomycin HCL ()
Vancomycin (hydrochloride) ()
Firvanq kit ()
Vancoled ()
Vancomycin (as hydrochloride) ()
Vancomycin monohydrochloride ()
Vanoled ()
NSC-757377 ()
Vancocin hydrochloride ()
Vancocin Matrigel ()
Vancor ()
Vancomycin, monohydrochloride ()
Firvanq ()
Vancocin ()
P&D ID
PD014826
CAS
1404-93-9
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antibacterial
First approval
1964
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Amphoteric glycopeptide antibiotic; interefers with cell wall syntehsis by bind to peptidoglycan
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
LOPAC library
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
16
Molecular Weight
1483.41
Hydrogen Bond Acceptors
25
Hydrogen Bond Donors
19
Rotatable Bonds
13
Ring Count
12
Aromatic Ring Count
5
cLogP
0.53
TPSA
530.49
Fraction CSP3
0.42
Chiral centers
18.0
Largest ring
16.0
QED
0.08
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Selectivity
Cell wall synthesis
Pathway
Immunology/Inflammation
Anti-infection
Autophagy
Target
Cell wall
antibiotic
Bacterial
Source data
